5-([1,2,4]triazolo[1,5-α]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline | 1254942-00-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 四氢异喹啉
• 英文名称: 5-([1,2,4]triazolo[1,5-α]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline
• 英文别名: (+)-5-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline；5-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline；4-(3,4-Dichlorophenyl)-5-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1,2,3,4-tetrahydroisoquinoline
• CAS: 1254942-00-1
• 化学式: C₂₁H₁₆Cl₂N₄
• 分子量: 395.291
• InChiKey: MESCUQOINARNDZ-UHFFFAOYSA-N

物化性质

• 密度：
  1.45±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.5
• 重原子数：
  27
• 可旋转键数：
  2
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.14
• 拓扑面积：
  42.2
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  2-溴-3',4'-二氯苯乙酮 在 盐酸 、 甲醇 、 sodium tetrahydroborate 、 硫酸 、 sodium iodide 作用下， 以 甲醇 、 乙醇 、 二氯甲烷 、 水 为溶剂， 反应 2.34h， 生成 5-([1,2,4]triazolo[1,5-α]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline
  参考文献：
  名称：

  [EN] ARYL, HETEROARYL, AND HETEROCYCLE SUBSTITUTED TETRAHYDROISOQUINOLINES AND USE THEREOF
  [FR] ARYLE, HÉTÉROARYLE ET TÉTRAHYDROISOQUINOLINES À HÉTÉROCYCLE SUBSTITUÉ ET LEUR UTILISATION

  摘要：

  本发明描述了新颖的芳基、杂芳基和非芳香杂环取代的四氢异喹啉化合物。这些化合物用于治疗各种神经和生理疾病。本发明还描述了制备这些化合物的方法。

  公开号：

  WO2010132437A1

文献信息

• [EN] CRYSTALLINE FORMS OF (S)-7-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)-4-(3,4-DICHLOROHPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE AND USE THEREOF<br/>[FR] FORMES CRISTALLINES DE (S)-7-([1,2,4]TRIAZOLO[1,5-A] PYRIDIN -6-YL)-4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE ET LEURS UTILISATIONS
  申请人：BRISTOL MYERS SQUIBB CO

  公开号：WO2010132487A1

  公开（公告）日：2010-11-18

  Novel [1,2,4]triazolo[1,5-a]pyridinyl-6-yl-substituted tetrahydroisoquinolines are described in the present invention. These compounds and crystalline forms SA1 and N-2 are used in the treatment of various neurological and physiological disorders. Methods of making these compounds and crystalline forms SA-1 and N-2 are also described in the present invention.

  本发明描述了新型[1,2,4]三唑并[1,5-a]吡啶基-6-基取代的四氢异喹啉化合物。这些化合物和结晶形式SA1和N-2被用于治疗各种神经和生理疾病。本发明还描述了制备这些化合物和结晶形式SA-1和N-2的方法。
• ARYL, HETEROARYL, AND HETEROCYCLE SUBSTITUTED TETRAHYDROISOQUINOLINES AND USE THEREOF
  申请人：Albany Molecular Research, Inc.

  公开号：US20150126517A1

  公开（公告）日：2015-05-07

  Novel aryl, heteroaryl, and non-aromatic heterocyle substituted tetrahydroisoquinolines are described in the present invention. These compounds are used in the treatment of various neurological and physiological disorders. Methods of making these compounds are also described in the present invention.

  本发明描述了新型芳基、杂环芳基和非芳杂环取代的四氢异喹啉。这些化合物用于治疗各种神经和生理疾病。本发明还描述了制造这些化合物的方法。
• CRYSTALLINE FORMS OF (S)-7-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)-4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE AND USE THEREOF
  申请人：Bristol-Myers Squibb Company

  公开号：US20140364441A1

  公开（公告）日：2014-12-11

  Novel [1,2,4]triazolo[1,5-a]pyridinyl-6-yl-substituted tetrahydroisoquinolines are described in the present invention. These compounds and crystalline forms SA1 and N-2 are used in the treatment of various neurological and physiological disorders. Methods of making these compounds and crystalline forms SA-1 and N-2 are also described in the present invention.

  本发明描述了[1,2,4]三唑并[1,5-a]吡啶基-6-基取代的四氢异喹啉类新型化合物。这些化合物和晶体形态SA1和N-2可用于治疗各种神经和生理障碍。本发明还描述了制备这些化合物和晶体形态SA-1和N-2的方法。
• 7-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)-4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE AND USE THEREOF
  申请人：Liu Shuang

  公开号：US20100292243A1

  公开（公告）日：2010-11-18

  Novel [1,2,4]triazolo[1,5-a]pyridinyl-6-yl-substituted tetrahydroisoquinolines are described in the present invention. These compounds and crystalline forms SA1 and N-2 are used in the treatment of various neurological and physiological disorders. Methods of making these compounds and crystalline forms SA-1 and N-2 are also described in the present invention.

  本发明描述了[1,2,4]三唑并[1,5-a]吡啶基-6-基取代四氢异喹啉类化合物。这些化合物及其晶体形态SA1和N-2用于治疗各种神经系统和生理障碍。本发明还描述了制备这些化合物和晶体形态SA-1和N-2的方法。
• CRYSTALLINE FORMS OF (S)-7-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)-4-(3,4-DICHLOROPHENYL)-1,2,3,4- TETRAHYDROISOQUINOLINE AND USE THEREOF
  申请人：WEI CHENKOU

  公开号：US20100292250A1

  公开（公告）日：2010-11-18

  Novel [1,2,4]triazolo[1,5-a]pyridinyl-6-yl-substituted tetrahydroisoquinolines are described in the present invention. These compounds and crystalline forms SA1 and N-2 are used in the treatment of various neurological and physiological disorders. Methods of making these compounds and crystalline forms SA-1 and N-2 are also described in the present invention.

  本发明描述了[1,2,4]三唑并[1,5-a]吡啶基-6-基取代的四氢异喹啉类化合物。这些化合物及其晶体形式SA1和N-2可用于治疗各种神经和生理疾病。本发明还描述了制备这些化合物和晶体形式SA-1和N-2的方法。